Enovis CORP
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on February 26, 2025.
By: /s/ MATTHEW L. TREROTOLA
Matthew L. Trerotola
Chair of the Board, Chief Executive Officer and Director
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.
Date: February 26, 2025
/s/ MATTHEW L. TREROTOLA
Matthew L. Trerotola
Chair of the Board, Chief Executive Officer and Director
(Principal Executive Officer)
/s/ PHILLIP B. BERRY
Phillip B. Berry
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
/s/ JOHN KLECKNER
John Kleckner
Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)
/s/ BRADY R. SHIRLEY
Brady R. Shirley
Director
/s/ DR. CHRISTINE ORTIZ
Dr. Christine Ortiz
Director
/s/ ANGELA S. LALOR
Angela S. Lalor
Director
/s/ LIAM J. KELLY
Liam J. Kelly
Director
/s/ A. CLAYTON PERFALL
A. Clayton Perfall
Director
/s/ BARBARA BODEM
Barbara Bodem
Director
/s/ RAJIV VINNAKOTA
Rajiv Vinnakota
Director
/s/ SHARON L. WIENBAR
Sharon L. Wienbar
Director
/s/ PHILIP OKALA
Philip Okala
Director
ENOVIS CORPORATION AND SUBSIDIARIES
SCHEDULE II–VALUATION AND QUALIFYING ACCOUNTS
| Balance atBeginningof Period | Charged to Cost andExpense(1) | Charged to OtherAccounts(2) | Write-Offs Write-Downs andDeductions | ForeignCurrencyTranslation | Balance atEnd ofPeriod | |
|---|---|---|---|---|---|---|
| (Dollars in thousands) | ||||||
| Year Ended December 31, 2024: | ||||||
| Allowance for credit losses | $9,731 | $10,617 | $8,893 | $(4,145) | $(630) | $24,466 |
| Valuation allowance for deferred tax assets | 101,650 | 52,815 | 4,789 | — | (2,811) | 156,443 |
| Year Ended December 31, 2023: | ||||||
| Allowance for credit losses | 7,965 | 4,836 | — | (3,221) | 151 | 9,731 |
| Valuation allowance for deferred tax assets | 93,542 | 4,646 | — | — | 3,462 | 101,650 |
| Year Ended December 31, 2022: | ||||||
| Allowance for credit losses | 6,589 | 2,552 | — | (963) | (213) | 7,965 |
| Valuation allowance for deferred tax assets | 111,812 | (12,126) | 537 | — | (6,681) | 93,542 |
(1)Amounts charged to expense are net of recoveries for the respective period.
(2)Represent fair value adjustments related to acquisitions, as well as amounts charged to Goodwill and reclassifications to deferred tax asset accounts.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.